238 related articles for article (PubMed ID: 18497722)
21. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Cusi K
Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes.
Wang CH; Wang CC; Wei YH
Ann N Y Acad Sci; 2010 Jul; 1201():157-65. PubMed ID: 20649552
[TBL] [Abstract][Full Text] [Related]
23. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dysfunction particularly in adipocytes may be an important triggering factor for type 2 diabetes.
Erol A
Med Hypotheses; 2006; 67(4):999-1000. PubMed ID: 16797855
[No Abstract] [Full Text] [Related]
25. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
[TBL] [Abstract][Full Text] [Related]
26. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
Qatanani M; Lazar MA
Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial disease: powerhouse of disease.
Lane N
Nature; 2006 Mar; 440(7084):600-2. PubMed ID: 16572142
[No Abstract] [Full Text] [Related]
29. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
Dumas JF; Simard G; Flamment M; Ducluzeau PH; Ritz P
Diabetes Metab; 2009 Jun; 35(3):159-67. PubMed ID: 19349201
[TBL] [Abstract][Full Text] [Related]
30. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome.
Lim S; Cho YM; Park KS; Lee HK
Ann N Y Acad Sci; 2010 Jul; 1201():166-76. PubMed ID: 20649553
[TBL] [Abstract][Full Text] [Related]
31. Adipose tissue and the immune system.
Pond CM
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):17-30. PubMed ID: 15946832
[TBL] [Abstract][Full Text] [Related]
32. Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome.
Cadoudal T; Leroyer S; Reis AF; Tordjman J; Durant S; Fouque F; Collinet M; Quette J; Chauvet G; Beale E; Velho G; Antoine B; Benelli C; Forest C
Biochimie; 2005 Jan; 87(1):27-32. PubMed ID: 15733733
[TBL] [Abstract][Full Text] [Related]
33. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
Hirabara SM; Curi R; Maechler P
J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
[TBL] [Abstract][Full Text] [Related]
34. A1 adenosine receptor: role in diabetes and obesity.
Dhalla AK; Chisholm JW; Reaven GM; Belardinelli L
Handb Exp Pharmacol; 2009; (193):271-95. PubMed ID: 19639285
[TBL] [Abstract][Full Text] [Related]
35. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
Ruan H; Pownall HJ
Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
[TBL] [Abstract][Full Text] [Related]
36. [Glucocorticoids, adipose metabolism and insulin resistance].
Xu C; Xu GH
Sheng Li Ke Xue Jin Zhan; 2009 Jan; 40(1):19-23. PubMed ID: 19408698
[TBL] [Abstract][Full Text] [Related]
37. [Exciting findings can change the view on the pathogenesis of type 2 diabetes. Impaired mitochondrial function can explain metabolic disorders in several organs].
Eriksson JW
Lakartidningen; 2004 Sep; 101(39):2992-3. PubMed ID: 15493637
[No Abstract] [Full Text] [Related]
38. Endothelin-1 stimulates human adipocyte lipolysis through the ET A receptor.
Eriksson AK; van Harmelen V; Stenson BM; Aström G; Wåhlén K; Laurencikiene J; Rydén M
Int J Obes (Lond); 2009 Jan; 33(1):67-74. PubMed ID: 18982011
[TBL] [Abstract][Full Text] [Related]
39. The importance of free fatty acids in the development of Type 2 diabetes.
Wilding JP
Diabet Med; 2007 Sep; 24(9):934-45. PubMed ID: 17725706
[TBL] [Abstract][Full Text] [Related]
40. Glucose sensing and the pathogenesis of obesity and type 2 diabetes.
Thorens B
Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S62-71. PubMed ID: 19079282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
